Uncategorised
A new platform has been designed in partnership with families affected by amyotrophic lateral sclerosis to make genetic testing more accessible to those with a family history, symptoms or diagnosis of ALS. Light the Way will deliver DNA testing and genetic counselling and has launched in the United States, with a Spanish language version to follow in January, and in the United Kingdom in early 2024.
French biopharmaceutical company Axoltis Pharma has announced promising results from its phase 1b clinical trial evaluating NX210c - an innovative therapy for neurodegenerative diseases and traumas.
A checklist has been developed to assess how current habits will impact future brain health, and what measures can be taken now to guard against neurological illness. By focusing on a list of 12 steps covering modifiable behaviours, adults can greatly reduce their risk of developing brain diseases such as dementia and stroke, according to a new study.
A new senior appointment has been made at the National Rehabilitation Centre (NRC) to help raise the profile of rehabilitation nurses and develop the range of skills they bring to patient care. Rebecca Kenny has been named Lead Nurse at the new £105million facility, which is being created as a focal point for rehab and neuro-rehab nationally.
An Edinburgh med-tech company has received almost half a million pounds in UK Government funding to develop an assistive robotic glove for stroke patients.
Two leading standards bodies have launched a new group aimed at connecting global neuroscience and genomic data to speed up research
"The recent advancements in neurotechnology will significantly transform various aspects of society, offering profound implications for healthcare, communication, and human capabilities" - Alexandrea Day, CEO of MetaBrain Labs
Pioneering technology to help support balance and gait deficits is helping brain injury survivors in returning to work, new statistics have shown. The Portable Neuromodulation Stimulator (PoNS) device has shown its positive impact in people with Multiple Sclerosis (MS) and stroke survivors, enabling them to regain movement ability they feared had been lost.
Hundreds of patients have been treated in an innovative rapid access pathway, which speeds up access to an initial neurological assessment. Born from the need to reduce pressures on A&E services during the COVID-19 pandemic, clinicians at The Walton Centre devised a criteria which would allow patients presenting with certain symptoms to be rapidly referred to the specialist neurosciences Trust.
The secrets of neurodegenerative diseases are being unravelled, one protein at a time, through a new groundbreaking study. Proteins misfolding and clumping together, a process known as aggregation, is a key feature seen in several neurological conditions, including Alzheimer's and Parkinson's diseases.
